Sunesis Pharmaceuticals, Inc. (SNSS) CEO to Ring The NASDAQ Stock Market Closing Bell
19 October 2011 - 1:34AM
What:
Sunesis Pharmaceuticals, Inc. [SNSS], a biopharmaceutical
company focused on the development and commercialization of new
oncology therapeutics for the treatment of solid and hematologic
cancers, will visit the NASDAQ MarketSite in New York City's Times
Square in conjunction with their analyst and institutional investor
meeting which will take place Wednesday, October 19th from 5:00 to
6:30 PM Eastern Time in New York City. A live webcast of the event
will be available on the Sunesis website at http://ir.sunesis.com.
A replay of the webcast will be archived on the "Calendar of
Events" page in the Investors and Media section of the Sunesis
website following the event.
In honor of the occasion Daniel N. Swisher, President & CEO,
will ring The NASDAQ Stock Market Closing Bell.
Where:
NASDAQ MarketSite – 4 Times Square – 43rd & Broadway –
Broadcast Studio
When:
Wednesday, October 19th, 2011 – 3:45 p.m. to 4:00 p.m.
ET
Company Contact
David Pitts
Argot Partners
(212) 600-1902
david@argotpartners.com
NASDAQ MarketSite:
Jen Knapp
(212) 401-8916
Jennifer.knapp@nasdaqomx.com
Feed Information: The entire Closing Bell is
available from 3:50 p.m. to 4:05 p.m. on AMC-3/C-3 (dl 3760H). The
feed can also be found on Ascent fiber 1623. If you have any
questions, please contact Jen Knapp (212) 401-8916.
Facebook and Twitter:
For multimedia features such as exclusive content, photo
postings, status updates and video of bell ceremonies please visit
our Facebook page at:
http://www.facebook.com/nasdaqomx
For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaqomx
Webcast: A live webcast of the NASDAQ Closing
Bell will be available at:
http://www.nasdaq.com/about/marketsitetowervideo.asx or
http://social.nasdaqomx.com.
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://www.nasdaq.com/reference/marketsite_events.stm and click on
the market close of your choice.
About Sunesis Pharmaceuticals, Inc.
(SNSS):
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, vosaroxin, in multiple
indications to improve the lives of people with cancer. For
additional information on Sunesis, please visit
www.sunesis.com.
About NASDAQ OMX:
The NASDAQ OMX Group, Inc. is the world's largest exchange
company. It delivers trading, exchange technology and public
company services across six continents, with more than 3,500 listed
companies. NASDAQ OMX offers multiple capital raising solutions to
companies around the globe, including its U.S. listings market,
NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX first North, and
the U.S. 144A sector. The company offers trading across multiple
asset classes including equities, derivatives, debt, commodities,
structured products and exchange-traded funds. NASDAQ OMX
technology supports the operations of over 70 exchanges, clearing
organizations and central securities depositories in more than 50
countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not
legal entities but describe the common offering from NASDAQ OMX
exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn,
Riga, and Vilnius. For more information about NASDAQ OMX, visit
http://www.nasdaqomx.com. *Please follow NASDAQ OMX on Facebook
(http://www.facebook.com/pages/NASDAQ-OMX/108167527653) and Twitter
(http://www.twitter.com/nasdaqomx).
-NDAQA-
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024